National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control, Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, Key Laboratory of Animal Vaccine Development of Ministry of Agriculture, College of Veterinary Medicine, South China Agricultural University, 483 Wushan Road, Tianhe District, Guangzhou, 510642, People's Republic of China.
Arch Virol. 2021 Jan;166(1):73-81. doi: 10.1007/s00705-020-04851-9. Epub 2020 Oct 16.
Avian infectious bronchitis (IB) is a highly contagious viral respiratory disease, caused by infectious bronchitis virus (IBV), that poses an important economic threat to the poultry industry. In recent years, genotypes GI-7, GI-13, and GI-19 have been the most prevalent IBV strains in China. However, in this study, we found that most IBV strains from southern China in 2016-2017 belonged to genotype GVI-1. This genotype, for which there is no vaccine, has been reported sporadically in the region. The GDTS13 strain, which caused severe IB outbreaks on the farms where it was isolated, was evaluated as a candidate vaccine strain. GDTS13 was serially passaged in specific-pathogen-free embryonated chicken eggs for 100 generations to produce GDTS13-F100. Safety testing indicated that GDTS13-F100 had no pathogenic effect on chickens. Additionally, GDTS13-F100 showed an excellent protective effect against GDTS13, with no clinical signs or virus shedding observed in immunized chickens challenged with the parent strain. These findings indicate that GVI-1 has become the most prevalent IBV genotype in southern China and that GDTS13-F100 may serve as an attenuated vaccine to protect against infection with this genotype.
禽传染性支气管炎(IB)是一种高度传染性的病毒性呼吸道疾病,由传染性支气管炎病毒(IBV)引起,对家禽业构成重要的经济威胁。近年来,基因型 GI-7、GI-13 和 GI-19 是中国最流行的 IBV 株。然而,在本研究中,我们发现 2016-2017 年中国南方的大多数 IBV 株属于基因型 GVI-1。该基因型没有疫苗,在该地区有零星报道。引起分离农场严重 IB 暴发的 GDTS13 株被评估为候选疫苗株。GDTS13 株在无特定病原体鸡胚中连续传代 100 代,产生 GDTS13-F100。安全性试验表明,GDTS13-F100 对鸡无致病作用。此外,GDTS13-F100 对 GDTS13 表现出极好的保护作用,免疫鸡攻毒后无临床症状或病毒脱落。这些发现表明 GVI-1 已成为中国南方最流行的 IBV 基因型,GDTS13-F100 可能作为减毒疫苗用于预防该基因型感染。